Technical Report 32: Costing Methods Used in VA Research, 1980-2012
Suggested CitationGehlert E, Jacobs J, Barnett PG. Costing Methods Used in VA Research, 1980-2012. Technical Report 32. Health Economics Resource Center, U.S. Department of Veterans Affairs. October 2016. https://www.herc.research.va.gov/include/page.asp?id=technical-report-costing-methods.
DisclaimersMany URLs are not live because they are VA intranet-only. Researchers with VA intranet access can access these sites by copying and pasting the URLs into their browser.
For a list of VA acronyms, please visit the VA acronym checker on theVA intranet at http://vaww.va.gov/Acronyms/fulllist.cfm.
1. Overview
The Health Economics Resource Center (HERC) of the U.S. Department of Veterans Affairs (VA) reviewed peer-reviewed publications to determine the methods and data sources used in studies of VA health care costs between 1980 and 2012. The review identified the number of published papers that used four principal methods of costing available to VA researchers and examined how practices differed in the last five years of the research that was reviewed. The review generated a bibliography of publications that used each of the four methods. The goal of this review was to identify priorities for HERC strategic planning.
HERC Average cost estimates. Comprehensive estimates of the cost of VA health services first became available in 1999 with the creation of the HERC average cost database. Prior to this time, each VA economic study had to develop its own estimate of the cost of VA care. HERC finds the expected Medicare cost of each service according to characteristics recorded in administrative data and adjusts these estimates so that they sum to the aggregate of VA health care expenditures. HERC named these data the average cost database, as they represent the national average cost of producing each service, given the characteristics recorded in administrative data. These estimates rely on measures of relative value developed for payments from the U.S. Medicare program. HERC produces estimates of the cost of inpatient stays and outpatient visits, and an annual person-level tally of costs incurred in different settings. The HERC data do not include prescriptions dispensed to outpatients.
MCA Activity based costing. VA uses activity based cost allocation, the Managerial Cost Accounting (MCA) system, to estimate the cost of every health system product and service. Staff activity, expenditures, and workload data are tracked to the level of production unit, and combined with a system of relative values to estimate costs of intermediate products (e.g. specific type of x-ray or lab test, visit to a certain clinic, or day of stay in a particular hospital unit). The cost of each encounter and each stay is found by summing all of the intermediate products used in caring for that patient. The first national data extracts from this system, which was then called Decision Support System, were released in 2000. The MCA cost estimates reflect differences between facilities in the cost of labor, supplies, and other input, as well as their efficiency in producing care. There are MCA data for each inpatient stay, outpatient visit, and prescription fill.
Micro-costing. When new health care interventions are developed, their cost is most often measured directly, as there is no established reimbursement or past record to be tracked in the activity based costing system. Direct measurement involves tabulation of the cost of staff time, supplies, and other input in a method known as micro-costing. Other methods of micro-costing include the pseudo bill method, which combines VA utilization with some measure of unit cost, and the regression method, where non-VA data have been used as parameters to estimate the cost of VA provided services.
Community care. Some care that VA provides to veterans is purchased from community providers. VA documents these purchases in a database of paid claims. In the early years of this review, this purchased care accounted for a small proportion of the total VA health care expenditures and was often ignored. In more recent years, VA spent more than 10% of its health care expenditures on this type of care. Community care was formerly called “fee basis care,” and more recently, “purchased care.”
2. Methods
The review searched PubMed, the database of the U.S. National Library of Medicine, for published studies that included in the title or abstract the words (COST* or ECONOMIC*) and (VETERAN*). The search included articles published between January 1, 1980 and September 27, 2012.
Papers were selected for abstraction if they reported on the cost of health care in the U.S. Department of Veterans Affairs and provided sufficient information to identify the costing method and data. The methods section of each paper was reviewed and the paper was assigned to one or more of the costing methods listed in Table 1. Abstraction was done by a Research Associate (EG), in consultation with a health economist (PB). The phrases used to assign studies to a category are described in Table 1.
| Method | Phrases |
|---|---|
| HERC average cost | HERC average cost data |
|
MCA activity based costing |
Decision Support System (DSS) |
| Micro-costing |
Time-and-motion studies |
| Community care |
Fee Basis care |
Studies were assigned to “average cost method” if it was indicated that the study used either the HERC method or a HERC dataset. The HERC outpatient datasets use a pseudo bill method, while medical- surgical inpatient costs are estimated by cost regression based on Diagnosis Related Group (DRG) weight and length of stay; other inpatient costs are estimating using average cost per day. Studies that used pseudo bill, cost regressions, or average cost per day were assigned to the micro-costing category unless they specifically referred to the HERC average cost method or the HERC databases.
The micro-costing method was broadly defined. It included direct measurement to find health costs, patient survey to find utilization to assign costs, use of reimbursement schedules, and cost estimates based on a count of visits, length of stay, or the DRG. These methods often employed VA datasets. The VA Financial Management System (FMS) and Personnel and Accounting Integrated Data System (PAID) and DSS ALB were used to assess labor costs for direct costing. Direct cost of medication was obtained from the Federal Supply Schedule (FSS) or the Pharmacy Benefits Management System (PBM); per capita cost estimates and per capita funding allocations were obtained from the VA Allocation Resource Center (ARC). Cost estimates were also based on aggregate expenditures reported in the VA Cost Distribution Report (CDR), an expense distribution system that was replaced by one component of MCA, the ALB.
3. Results
There were 415 studies that met the original search criteria, 160 from 1980-2007, and 255 from 2008-2012. There were 259 peer-reviewed publications the met inclusion criteria. There were 125 publications in the five years 2008-2012, compared to 134 publications in the prior 18 years. Nearly have of the papers selected for study were published in the last 5 years of the 23 year period.
The selected studies report on the cost of VA health services and provided sufficient information to assign them to one more of the costing methods. Table 2 characterizes the number of publications by method. Over the entire review period, micro-costing was the most frequently employed method (58.7%), followed by MCA activity based data (46.7%), HERC average cost data (16.2%), and use of community care claims (4.6%). These percentages sum to more than 100%, as a given study may employ more than one method.
Starting in 2008, MCA activity-based cost data became the most important source of cost data, and was used in 76.0% of included studies. MCA activity-based costing was used more often than the HERC average cost method in both time frames.
| VA Cost Method | 1980-2007 n (%) |
2008-2012 n (%) |
All n (%) |
|---|---|---|---|
| HERC Average Cost Data | 12(9.0%) | 31 (24.8%) | 42 (16.2%) |
| MCA Activity Based Costing | 26 (19.4%) | 95 (76.0%) | 121 (46.7%) |
| Micro-costing | 115 (85.8%) | 36 (28.8%) | 152 (58.7%) |
| Community Care | 1 (0.7%) | 11 (8.8%) | 12 (4.6%) |
| Total | 134 | 125 | 259 |
Table 3 cites the studies using each method in each time frame. Some studies are cited in more than one cell of the table.
| VA Cost Method | 1980-2007 | 2008-2012 |
|---|---|---|
| HERC Average Cost Data | 1-12 | 13-43 |
| MCA Activity Based Costing | 1,4,9,44-66 | 15-19,21,23,24,67-108, 30,36,37,41,42,109-148 |
| Micro-costing | 7,44-46,50-52,54,57,59-65,149-247 | 13,15,25,29,31,72,85-90,94,102,114,120-124,129,133,135,138,145,148,248-257 |
| Community Care | 236 | 34,35,38,41,96,141,144,145,148,236,258 |
4. Conclusions
The review identified costing methods used in 259 VA studies between 1980 and 2012. The studies were conducted over a wide range of clinical areas and using a range of costing methods. Nearly half of the studies were from the last 5 years of this 23 year long time period.
The activity based cost estimates in the MCA national data extracts have become the predominant method of determining VA health care costs in peer reviewed-publications. MCA data, and to a lesser extent the HERC average cost data, supplanted micro-costing methods.
Limitations. The scope of this review was limited to published articles indexed in PubMed. Article selection and abstraction for the period 1980-2007 was done in 2008. Articles published in 2008-2012 were abstracted four years later, in 2012. The abstraction of the more recent studies may have been more complete.
5. References
1. Cowper D, Yu W, Kuebeler M, Kubal JD, Manheim LM, Ripley BA. Using GIS in government: an overview of the VHA's Healthcare Atlas, FY-2000. J Med Syst 2004;28(3):257-69.
2. Hawthorne WB, Green EE, Gilmer T, Garcia P, Hough RL, Lee M, et al. A randomized trial of short-term acute residential treatment for veterans. Psychiatr Serv 2005;56(11):1379-86.
3. Maciejewski ML, Liu C-F, Derleth A, McDonell M, Anderson S, Fihn SD. The performance of administrative and self-reported measures for risk adjustment of Veterans Affairs expenditures. Health Services Research 2005;40(3):887-904.
4. Miller DR, Gardner JA, Hendricks AM, Zhang Q, Fincke BG. Health care resource utilization and expenditures associated with the use of insulin glargine. Clin Ther 2007;29(3):478-87.
5. Sloan KL, Montez-Rath ME, Spiro A, 3rd, Christiansen CL, Loveland S, Shokeen P, et al. Development and validation of a psychiatric case-mix system. Med Care 2006;44(6):568-80.
6. Stroupe KT, Morrison DA, Hlatky MA, Barnett PG, Cao L, Lyttle C, et al. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients. Circulation 2006;114(12):1251-7.
7. Wagner TH, Chen S, Barnett PG. Using average cost methods to estimate encounter-level costs for medical-surgical stays in the VA. Med Care Res Rev 2003;60(3 Suppl):15S-36S.
8. Yu W, Cowper D, Berger M, Kuebeler M, Kubal J, Manheim L. Using GIS to profile health-care costs of VA Quality-Enhancement Research Initiative diseases. Journal of Medical Systems 2004;28(3):271-85.
9. Yu W, Ravelo A, Wagner TH, Barnett PG. The relationships among age, chronic conditions, and healthcare costs. Am J Manag Care 2004;10(12):909-16.
10. Yu W, Ren XS, Lee AF, Herz L, Huang YH, Kazis LE. Association of co-morbidities with prescribing patterns and cost savings: olanzapine versus risperidone for schizophrenia. Pharmacoeconomics 2006;24(12):1233-48.
11. Yu W, Wagner TH, Barnett PG. Determinants of cost among people who died in VA nursing homes. Med Care Res Rev 2006;63(4):477-98.
12. Yu W, Wagner TH, Chen S, Barnett PG. Average cost of VA rehabilitation, mental health, and long-term hospital stays. Med Care Res Rev 2003;60(3 Suppl):40S-53S.
13. Abraham NS, Hartman C, Hasche J. Reduced hospitalization cost for upper gastrointestinal events that occur among elderly veterans who are gastroprotected. Clin Gastroenterol Hepatol 2010;8(4):350-6.
14. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Expenditures in mental illness and substance use disorders among veteran clinic users with diabetes. J Behav Health Serv Res 2008;35(3):290-303.
15. Barnett PG, Ananth L, Gould MK. Cost and outcomes of patients with solitary pulmonary nodules managed with PET scans. Chest 2010;137(1):53-9.
16. Carey K, T. S. Measuring the cost of hospital adverse patient safety events. Health Econ. 2011;20(12):13.
17. Carey K, Montez-Rath ME, Rosen AK, Christiansen CL, Loveland S, Ettner SL. Use of VA and Medicare services by dually eligible veterans with psychiatric problems. Health Serv Res 2008;43(4):1164-83.
18. Chapko MK, Liu CF, Perkins M, Li YF, Fortney JC, Maciejewski ML. Equivalence of two healthcare costing methods: bottom-up and top-down. Health Econ 2008.
19. Dewan NA, Rice KL, Caldwell M, DE. H. Economic evaluation of a disease management program for chronic obstructive pulmonary disease. COPD. 2011;8(3):153-9.
20. Domino M, Maxwell J, Cody M, Cheal K, Busch A, Stone WV, et al. The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care: Results from the randomized PRISM-E Study. Ageing Int 2008;32(2):108-127.
21. Doyle JJ, Ewer SM, Wagner TH. Returns to physician human capital evidence from patients randomized to physician teams. Journal of Health Economics 2010;29(6):866-882.
22. Homaifar BY, Harwood JE, Wagner TH, Brenner LA. Description of outpatient utilization and costs in group of veterans with traumatic brain injury. Journal of Rehabilitation Research and Development 2009;46(8):1003-1010.
23. Hsu JL, Siroka AM, Smith MW, Holodniy M, Meduri GU. One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System. International Journal of Infectious Disease 2011;15(6):e382-387.
24. Humphreys K, Wagner TH, M. G. If substance use disorder treatment more than offsets its costs, why don't more medical centers want to provide it? A budget impact analysis in the Veterans Health Administration. J Subst Abuse Treat. 2011;41(3):243-51.
25. Hynes DM, Stroupe KT, Fischer MJ, Reda DJ, Manning W, Browning MM, et al. Comparing VA and Private Sector Healthcare Costs for End-stage Renal Disease. Med Care. 2012;50(2):10.
26. Maciejewski ML, Smith VA, Livingston EH, Kavee AL, Kahwati LC, Henderson WG, et al. Health care utilization and expenditure changes associated with bariatric surgery. Med Care. 2010;48(1):989-98.
27. Maciejewski ML, Liu C-F, Fihn SD. Performance of comorbidity, risk adjustment, and functional status measures in expenditure prediction for patients with diabetes. Diabetes Care 2009;32(1):75-80.
28. Maciejewski ML, Livingston EH, Smith VA, Kahwati LC, Henderson WG, Arterburn DE. Health expenditures among high-risk patients after gastric bypass and matched controls. Arch Surg 2012;147(7):633-40.
29. Onukwugha E, Mullins CD, Delisle S. Using Cost-Effectiveness Analysis to Sharpen Formulary Decision-Making: The Example of Tiotropium at the Veterans Affairs Health Care System. Value Health 2008.
30. Petersen LA, Byrne MM, Daw CN, Hasche J, Reis B, Pietz K. Relationship between clinical conditions and use of Veterans Affairs Health Care among Medicare-enrolled Veterans. Health Services Research 2010;45(3):762-791.
31. Rivard PE, Luther SL, Christiansen CL, Shibei Z, Loveland S, Elixhauser A, et al. Using patient safety indicators to estimate the impact of potential adverse events on outcomes. Med Care Res Rev 2008;65(1):67-87.
32. Shen Y, Sambamoorthi U, Rajan M, Miller D, Banerjea R, Pogach L. Obesity and expenditures among elderly Veterans Health Administration users with diabetes. Popul Health Manag 2009;12(5):255-64.
33. Sinnott PL, Cheng A, Wagner TH, Goetz LL, Ottomanelli L. Cost-effectiveness analysis of the spinal cord injury vocational integration program (SCI-VIP). Topics in Spinal Cord Injury Rehabilitation 2011;16(4):80-88.
34. Smith MW, Lemke S, J. S. Substance use disorders and health care costs among veterans affairs nursing home residents. Med Care. 2011;49(6):538-44.
35. Stroupe KT, Fischer MJ, Kaufman JS, O'Hare AM, Sohn MW, Browning MM, et al. Predialysis nephrology care and costs in elderly patients initiating dialysis. Med Care. 2011;49(3):248-56.
36. Stroupe KT, Lederle FA, Matsumura JS, Kyriakides TC, Jonk YC, Ge L, et al. Cost-effectiveness of open vs endovascular repair of abdominal aortic aneurysm in the OVER trial. J Vasc Surg 2012;56(4):901-9.e2.
37. Taylor BC, Hagel EM, Carlson KF, Cifu DX, Cutting A, Bidelspach DE, et al. Prevalence and costs of co-occurring traumatic brain injury with and without psychiatric disturbance and pain among Afghanistan and Iraq War Veteran V.A. users. Med Care 2012;50(4):342-6.
38. Trivedi AN, Grebla RC, Jiang L, Yoon J, Mor J, Kizer KW. Duplicate federal payments for dual enrollees in medicare advantage plans and the veterans affairs health care system JAMA 2012;308(1):67-72.
39. Valenstein M, Eisenberg D, McCarthy JF, Austin KL, Ganoczy D, Kim HM, et al. Service implications of providing intensive monitoring during high-risk periods for suicide among VA patients with depression. Psychiatr Serv 2009;60(4):439-44.
40. Wiley-Exley E, Domino ME, Maxwell J, Levkoff SE. Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study. J Ment Health Policy Econ 2009;12(4):205-13.
41. Yoon J, Scott JY, Phibbs CS, Frayne SM. Trends in rates and attributable costs of conditions among female VA patients, 2000 and 2008. Women's Health Issues 2012;22(3):e337-e344.
42. Young-Hughes S, LA. S. Spinal cord injury/disorder teleconsultation outcome study. Rehabil Nurs. 2011;36(4):172.
43. Yu W, Smith B, Kim S, Chow A, Weaver FM. Major medical conditions and VA healthcare costs near end of life for veterans with spinal cord injuries and disorders. J Rehabil Res Dev 2008;45(6):831-9.
44. Barnett PG, Lin P, Wagner TH. Estimating the costs of cardiac care provided by the hospitals of the US Department of Veterans Affairs. In: Weintraub WS, editor. Contemporary Cardiology: Cardiovascular Health Care Economics. Totowa, NJ: Humana Press; 2003. p. 15-29.
45. Barnett PG, Rodgers JH. Use of the Decision Support System for VA cost-effectiveness research. Med Care 1999;37(4 Suppl Va):AS63-70.
46. Berger M, Gould MK, Barnett PG. The cost of positron emission tomography in six United States Veterans Affairs hospitals and two academic medical centers. AJR Am J Roentgenol 2003;181(2):359-65.
47. Dang S, Ma F, Nedd N, Aguilar EJ, Roos BA. Differential resource utilization benefits with Internet-based care coordination in elderly veterans with chronic diseases associated with high resource utilization. Telemed J E Health 2006;12(1):14-23.
48. Frayne SM, Yu W, Yano EM, Ananth L, Iqbal S, Thrailkill A, et al. Gender and Use of Care: Planning for Tomorrow's Veterans Health Administration. J Womens Health (Larchmt) 2007;16(8):1188-1199.
49. Hatmaker AR, Donahue RM, Tarpley JL, Pearson AS. Cost-effective use of breast biopsy techniques in a Veterans health care system. Am J Surg 2006;192(5):e37-41.
50. Hendricks AM, Lotchin TR, Hutterer J, Swanson J, Kenneally K. Evaluating VA patient-level expenditures: decision support system estimates and Medicare rates. Medical Care 2003;41(6 Suppl):II111-7.
51. Lum G. Utilization and cost effectiveness of standardized testing for screening and confirmation of drugs of abuse in urine. Annals of Clinical & Laboratory Science 2002;32(4):387-392.
52. Maciejewski ML, Chapko MK, Hedeen AN, Fortney JC. VA community-based outpatient clinics: cost performance measures. Medical Care 2002;40(7):587-595.
53. Maciejewski ML, Perkins M, Li YF, Chapko M, Fortney JC, Liu CF. Utilization and expenditures of veterans obtaining primary care in community clinics and VA medical centers: an observational cohort study. BMC Health Serv Res 2007;7:56.
54. Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 2000;20(10):1149-58.
55. Mauchley DC, Lynge DC, Langdale LA, Stelzner MG, Mock CN, Billingsley KG. Clinical utility and cost-effectiveness of routine preoperative computed tomography scanning in patients with colon cancer. American Journal of Surgery 2005;189(5):512-7; discussion 517.
56. McFall M, Saxon AJ, Thaneemit-Chen S, Smith MW, Joseph AM, Carmody TP, et al. Integrating smoking cessation into mental health care for post-traumatic stress disorder. Clin Trials 2007;4(2):187-89.
57. Menke TJ, Homan RH, Kashner TM. Determining costs in VA: research design problems and solutions illustrated with case studies. Medical Care 1999;37(4 Suppl.):AS18-AS26.
58. Nugent G, Hendricks A. Estimating private sector values for VA health care: an overview. Med Care 2003;41(6 Suppl):II2-10.
59. Penrod JD, Deb P, Luhrs C, Dellenbaugh C, Zhu CW, Hochman T, et al. Cost and utilization outcomes of patients receiving hospital-based palliative care consultation. J Palliat Med 2006;9(4):855-60.
60. Sales AE, Liu C-F, Sloan KL, Malkin J, Fishman PA, Rosen AK, et al. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population. Medical Care 2003;41(6):753-60.
61. Saxon AJ, Malte CA, Sloan KL, Baer JS, Calsyn DA, Nichol P, et al. Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment. Med Care 2006;44(4):334-42.
62. Sloan KL, Sales AE, Liu C-F, Fishman P, Nichol P, Suzuki NT, et al. Construction and Characteristics of the RxRisk-V: A VA-Adapted Pharmacy-Based Case-mix Instrument. Med Care 2003;41(6):761-74.
63. Vachharajani TJ, Atray NK. Interventional nephrology in a federal hospital: economics of health care. Semin Dial 2006;19(5):421-4.
64. Yaisawarng S, Burgess JF, Jr. Performance-based budgeting in the public sector: an illustration from the VA health care system. Health Econ 2006;15(3):295-310.
65. Yee JL, Hasson NK, Schreiber DH. Drug-related emergency department visits in an elderly veteran population. Ann Pharmacother 2005;39(12):1990-5.
66. Zaman A, Goldberg Arnold RJ, Pettit KG, Kaniecki DJ, Benner K, Zacker C, et al. Cost of treating an episode of variceal bleeding in a VA setting. Am J Gastroenterol 2000;95(5):1323-30.
67. Allen KD, Oddone EZ, Coffman CJ, Datta SK, Juntilla KA, Lindquist JH, et al. Telephone-based self-management of osteoarthritis: a randomized trial. Annals of Internal Medicine 2010;153(9):570-W199.
68. Allen KD BH, Brock DS, Chapman JG, Chatterjee R, Coffman CJ, Datta SK, Dolor RJ, Jeffreys AS, Juntilla KA, Kruszewski J, Marbrey LE, McDuffie J, Oddone EZ, Sperber N, Sochacki MP, Stanwyck C, Strauss J, Yancy WS Jr. Patient and Provider Interventions for Managing Osteoarthritis in Primary Care: Protocols for Two Randomized Controlled Trials. BMC Musculoskelet Disord. 2012;13(1):60.
69. Atia A, Murthy R, Bailey BA, Manning T, Garrett LL, Youssef D, et al. Vitamin D status in veterans with inflammatory bowel disease: relationship to health care costs and services. Mil Med. 2011;176(6):711-4.
70. Bailey BA, Manning T, Peiris AN. Vitamin D Testing Patterns Among Six Veterans Medical Centers in the Southeastern United States: Links With Medical Costs. Military Medicine 2012;177(1):70-76.
71. Bakaeen FG, Sethi G, Wagner TH, Kelly R, Lee K, Upadhyay A, et al. Coronary Artery Bypass Graft Patency: Residents Versus Attending Surgeons. Ann Thorac Surg 2012;94(2):482-8.
72. Barnett PG. An improved set of standards for finding cost for cost-effectiveness analysis. Medical Care 2009;47(7):S82-S88.
73. Barnett PG. Comparison of costs and utilization among buprenorphine and methadone patients. Addiction 2009;104(6):982-992.
74. Barnett PG, Chow A, Joyce VR, Bayoumi AM, Griffin SC, Nosyk B, et al. Determinants of the cost of health services used by veterans with HIV. Med Care. 2011;49(9):848-56.
75. Barnett PG, Scott JY, Krystal JH, Rosenheck RA. Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia. J Clin Psychiatry 2012;73(5):696-702.
76. Barnett PG, Scott JY, RA; R, Group. CS. How do clinical trial participants compare to other patients with schizophrenia? Schizophr Res. 2011;130(1-3):34-9.
77. Barnett PG, Trafton JA, Humphreys K. The cost of concordance with opiate substitution treatment guidelines. J Subst Abuse Treat 2010;39(2).
78. Bendixen RM, Levy CE, Olive ES, Kobb RF, Mann WC. Cost effectiveness of a telerehabilitation program to support chronically ill and disabled elders in their homes. Telemed J E Health 2009;15(1):31-8.
79. Benzer JK SJ, Williams S, Burgess JF. One-Year Cost Implications of Using Mental Health Care After Discharge From a General Medical Hospitalization. Psychiatr Serv 2012.
80. Bosworth HB, Olsen MK, Dudley T, Orr M, Goldstein MK, Datta SK, et al. Patient education and provider decision support to control blood pressure in primary care: A cluster randomized trial. American Heart Journal 2009;157(3):450-456.
81. Bounthavong M, Zargarzadeh A, Hsu DI, DJ. V. Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus: complicated skin and skin structure infection using Bayesian methods for evidence synthesis. Value Health. 2011;14(5):631-9.
82. Buchholz J, Malte C, Calsyn D, Baer J, Nichol P, Kivlahan D, et al. Associations of housing status with substance abuse treatment and service use outcomes among Veterans. Psychiatric Services 2010;61(7):698-706.
83. Caldeiro RM, Malte CA, Calsyn DA, Baer JS, Nichol P, Kivlahan DR, et al. The association of persistent pain with out-patient addiction treatment outcomes and service utilization. Addiction 2008;103(12):1996-2005.
84. Carey K, Stefos T, Shibei Zhao, Borzecki AM, AK. R. Excess costs attributable to postoperative complications. Med Care Res Rev. 2011;68(4):490-503.
85. Chan D, Cheadle AD, Reiber G, Unutzer J, Chaney EF. Health care utilization and its costs for depressed veterans with and without comorbid PTSD symptoms. Psychiatr Serv 2009;60(12):1612-7.
86. Chapko MK, Manheim LM, Guihan M, Sullivan JH, Zhou XH, Wang L, et al. Assisted living pilot program: utilization and cost findings. J Aging Health 2009;21(1):208-25.
87. Darkins A, Ryan P, Kobb R, Foster L, Edmonson E, Wakefield B, et al. Care Coordination/Home Telehealth: the systematic implementation of health informatics, home telehealth, and disease management to support the care of veteran patients with chronic conditions. Telemed J E Health 2008;14(10):1118-26.
88. Datta SK, Oddone EZ, Olsen MK, Orr M, McCant F, Gentry P, et al. Economic analysis of a tailored behavioral intervention to improve blood pressure control for primary care patients. Am Heart J 2010;160(2):257-63.
89. de Perio MA, Tsevat J, Roselle GA, Kralovic SM, Eckman MH. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. Arch Intern Med 2009;169(2):179-87.
90. Dickinson KC, Sharma R, Duckart JP, Corson K, Gerrity MS, Dobscha SK. VA healthcare costs of a collaborative intervention for chronic pain in primary care. Med Care 2010;48(1):38-44.
91. Dubbert PM, Morey MC, Kirchner KA, Meydrech EF, Grothe K. Counseling for home-based walking and strength exercise in older primary care patients. Archives of Internal Medicine 2008;168(9):979-986.
92. Egede LE, Gebregziabher M, Lynch CP, Gilbert GE, Echols C. Longitudinal ethnic differences in multiple cardiovascular risk factor control in a cohort of US adults with diabetes. Diabetes Research and Clinical Practice 2011;94(3):385-394.
93. Egede LE, Gebregziabher M, Dismuke CE, Lynch CP, Axon RN, Zhao Y, et al. Medication Nonadherence in Diabetes: Longitudinal effects on costs and potential cost savings from improvement. Diabetes Care 2012.
94. Filice GA, Nyman JA, Lexau C, Lees CH, Bockstedt LA, Como-Sabetti K, et al. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infect Control Hosp Epidemiol 2009;31(4):365-73.
95. Fortney JC, Maciejewski ML, Tripathi SP, Deen TL, JM. P. A budget impact analysis of telemedicine-based collaborative care for depression. Med Care. 2011;49(9):872-80.
96. Frahm KA, Barnett SD, LM. B. Trends in hospice utilization across age among the veteran population. Am J Hosp Palliat Care. 2011;28(6):424-8.
97. French DD, Campbell RR, Rubenstein LZ, Spehar AM. Acquisition costs and use of Medicare Part D-excluded drugs in Veterans Health Administration long-stay nursing home residents: a national, descriptive, secondary data analysis. Drugs Aging 2008;25(10):855-60.
98. French DD, Siddharthan K, Bass E, Campbell RR. Benchmark data on the utilization and acquisition costs of central nervous system and muscular skeletal drugs among veterans with combat-related injuries. Mil Med 2008;173(7):626-8.
99. Frick KD, Burton LC, Clark R, Mader SI, Naughton WB, Burl JB, et al. Substitutive Hospital at Home for older persons: effects on costs. Am J Manag Care 2009;15(1):49-56.
100. Garrido MM DP, Burgess JF Jr, Penrod JD. Choosing Models for Health Care Cost Analyses: Issues of Nonlinearity and Endogeneity. Health Serv Res. 2012.
101. Harris A, Kivlahan D, Barnett P, Finney J. Longer Length of Stay Is Not Associated with Better Outcomes in VHA’s Substance Abuse Residential Rehabilitation Treatment Programs. The Journal of Behavioral Health Services and Research 2012;39(1):68-79.
102. Hay JW, Lawler E, Yucel K, Guo A, Balzer T, Gaziano JM, et al. Cost Impact of Diagnostic Imaging for Lower Extremity Peripheral Vascular Occlusive Disease. Value Health 2008.
103. Hayes J, Vogel B, Reker DM. Factors associated with VHA costs of care for first 12 months after first stroke. J Rehabil Res Dev 2008;45(9):1375-84.
104. Healey CM, Kumbhani DJ, Healey NA, Crittenden MD, Gibson SF, Khuri SF. Impact of intraoperative myocardial tissue acidosis on postoperative adverse outcomes and cost of care for patients undergoing prolonged aortic clamping during cardiopulmonary bypass. Am J Surg 2009;197(2):203-10.
105. Hendricks A, Gardner J, Frakt A, Gilden D, Prentice J, Wolfsfeld L, et al. What can Medicaid data add to research on VA patients? Journal of Rehabilitation Research and Development 2010;47(8):773-780.
106. Hockenberry JM, Burgess JF Jr, Glasgow J, Vaughan-Sarrazin M, PJ. K. Cost of Readmission: Can the Veterans Health Administration (VHA) Experience Inform National Payment Policy? Med Care 2012.
107. Hubbard Winkler SL, Wu S, Cowper Ripley DC, Groer S, H. H. Medical utilization and cost outcomes for poststroke veterans who receive assistive technology devices from the Veterans Health Administration. . J Rehabil Res Dev. 2011;48(2):125-34.
108. Kamath AS, Sarrazin MV, Vander Weg MW, Cai X, Cullen J, Katz DA. Hospital Costs Associated with Smoking in Veterans Undergoing General Surgery. Journal of the American College of Surgeons 2012 Jun;214(6):901-908.e1.
109. Lee ES, Pickett E, Hedayati N, Dawson DL, Pevec WC. Implementation of an aortic screening program in clinical practice: implications for the Screen For Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act. J Vasc Surg 2009;49(5):1107-11.
110. Lee TA, Schumock GT, Bartle B, Pickard AS. Mortality risk in patients receiving drug regimens with Theophylline for Chronic Obstructive Pulmonary Disease. Pharmacotherapy 2009;29(9):1039-1053.
111. Leslie DL, Goulet J, Skanderson M, Mattocks K, Haskell S, C. B. VA health care utilization and costs among male and female veterans in the year after service in Afghanistan and Iraq. Mil Med. 2011;176(3):265-9.
112. Li YF, Wong ES, Sales AE, Sharp ND, Needleman J, Maciejewski ML, et al. Nurse staffing and patient care costs in acute inpatient nursing units. Med Care. 2011;49(8):708-15.
113. Liu CF, Collins MP, Souza PE, B. Y. Long-term cost-effectiveness of screening strategies for hearing loss. J Rehabil Res Dev. 2011;48(3):235-43.
114. Liu CF, Sharp ND, Sales AE, Lowy E, Maciejewski ML, Needleman J, et al. Line authority for nurse staffing and costs for acute inpatient care. Inquiry 2009;46(3):339-51.
115. Maciejewski ML, Liu CF, Kavee AL, Olsen MK. How price responsive is the demand for specialty care? Health Economics 2011.
116. Marshall CL, Chen GJ, Robinson CN, Balentine CJ, Anaya DA, Artinyan A, et al. Establishment of a minimally invasive surgery program leads to decreased inpatient cost of care in veterans with colon cancer. Am J Surg. 2010;200(5):632-5.
117. Morgan RO, Petersen LA, Hasche JC, Davila JA, Byrne MM, Osemene NI, et al. VHA pharmacy use in veterans with Medicare drug coverage. Am J Manag Care 2009;15(3):e1-8.
118. Nelson RE, Hicken B, West A, Rupper R. The Effect of Increased Travel Reimbursement Rates on Health Care Utilization in the VA. The Journal of Rural Health 2012;28(2):192-201.
119. North L, Kehm L, Bent K, Hartman T. Can home-based primary care: cut costs? Nurse Pract 2008;33(7):39-44.
120. Nyman JA, Lees CH, Bockstedt LA, Filice GA, Lexau C, Lesher LJ, et al. Cost of screening intensive care unit patients for methicillin-resistant Staphylococcus areus in hospitals. Am J Infect Control 2011;39(1):27-34.
121. Patel JJ, Mendes MA, Bounthavong M, Christopher ML, Boggie D, Morreale AP. Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model. J Eval Clin Pract 2012 Apr;18(2):247-55.
122. Peiris AN, Bailey BA, Manning T. The relationship of vitain D deficiency to health care costs in veterans. Military Medicine 2008;173(12):1214-1218.
123. Penrod JD, Deb P, Dellenbaugh C, Burgess JF, Jr., Zhu CW, Christiansen CL, et al. Hospital-based palliative care consultation: effects on hospital cost. J Palliat Med 2010;13(8):973-9.
124. Pyne JM, Fortney JC, Tripathi SP, Maciejewski ML, Edlund MJ, Williams DK. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression. Arch Gen Psychiatry 2010;67(8):812-21.
125. Quigley PA, Campbell RR, Bulat T, Olney RL, Buerhaus P, J. N. Incidence and cost of serious fall-related injuries in nursing homes. Clin Nurs Res. 2011.
126. Rajan M, Lai K-C, Tseng C-L, Qian S, Selim A, Kazis L, et al. Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes. Quality of Life Research 2012:1-12.
127. Robinson TN, Wu DS, Stiegmann GV, M. M. Frailty predicts increased hospital and six-month healthcare cost following colorectal surgery in older adults. Am J Surg. 2011;202(5):4.
128. Schreyögg J, T. S. The trade-off between costs and outcomes: the case of acute myocardial infarction. Health Serv Res 2010;45(6 Pt 1):1585-601.
129. Sharafkhaneh A, Petersen NJ, Yu HJ, Dalal AA, Johnson ML, Hanania NA. Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis 2010;5:125-32.
130. Siddharthan K, Scott S, Bass E, Nelson A. Rehabilitation outcomes for veterans with polytrauma treated at the Tampa VA. Rehabil Nurs 2008;33(5):221-5.
131. Simpson TL, Moore SA, Luterek J, Varra AA, Hyerle L, Bush K, et al. Psychiatric Correlates of Medical Care Costs Among Veterans Receiving Mental Health Care. Journal of Interpersonal Violence 2012;27(6):1005-1022.
132. Smith MW, An LC, Fu SS, Nelson DB, AM. J. Cost-effectiveness of an intensive telephone-based intervention for smoking cessation. J Telemed Telecare. 2011;17(8):437-40.
133. Smith MW, Chen S, Siroka AM, Hamlett-Berry K. Using policy to increase prescribing of smoking cessation medications in the VA healthcare system. Tob Control 2010;19(6):507-11.
134. Smith MW, Hill ML, Hopkins KL, Kiratli BJ, Cronkite RC. A modeled analysis of telehealth methods for treating pressure ulcers after spinal cord injury. Int J Telemed Appl 2012;2012:729492.
135. Stroupe KT, Stelmack JA, Tang XC, Reda DJ, Moran D, Rinne S, et al. Economic evaluation of blind rehabilitation for veterans with macular diseases in the Department of Veterans Affairs. Ophthalmic Epidemiol 2008;15(2):84-91.
136. Vaughan-Sarrazin M, Bayman L, Rosenthal G, Henderson W, Hendricks A, JJ. C. The business case for the reduction of surgical complications in VA hospitals. Surgery. 2011;149(4):474-83.
137. Vaughan-Sarrazin MS, Bayman L, JJ. C. Costs of postoperative sepsis: the business case for quality improvement to reduce postoperative sepsis in veterans affairs hospitals. Arch Surg. 2011;146(8):944-51.
138. Vogel WB, Barnett TE, Reker D. Cost differences in VHA acute and subacute rehabilitation units: implications for VHA resource planning. J Rehabil Res Dev 2010;47(5):431-9.
139. Wagner TH, Lo AC, Peduzzi P, Bravata DM, Huang GD, Krebs HI, et al. An economic analysis of robot-assisted therapy for long-term upper-limb impairment after stroke. Stroke. 2011;42(9):2630-2.
140. Wagner TH, Sethi G, Holman W, Lee K, Bakaeen FG, Upadhyay A, et al. Costs and quality of life associated with radial artery and saphenous vein cardiac bypass surgery: results from a Veterans Affairs multisite trial. Am J Surg. 2011;202(5):4.
141. Wagner TH, Sinnott P, Siroka AM. Mental health and substance use disorder spending in the Department of Veterans Affairs, Fiscal Years 2000-2007. Psychiatric Services 2011;62(4):389-395.
142. Wakefield H, Vaughan-Sarrazin M, Cullen JJ. Influence of obesity on complications and costs after intestinal surgery. The American Journal of Surgery 2012(0).
143. Wang V, Smith VA, Bosworth HB, Oddone EZ, Olsen MK, McCant F, et al. Economic evaluation of telephone self-management interventions for blood pressure control. Am Heart J 2012;163(6):980-6.
144. Watkins KE, Pincus HA, Paddock S, Smith B, Woodroffe A, Farmer C, et al. Care for veterans with mental and substance use disorders: good performance, but room to improve on many measures. Health Aff (Millwood). 2011;30(11):10.
145. Wray LO, Shulan MD, Toseland RW, Freeman KE, Vasquez BE, Gao J. The effect of telephone support groups on costs of care for veterans with dementia. Gerontologist 2010;50(5):623-31.
146. Yoon J, Scott JY, Phibbs CS, TH. W. Recent trends in Veterans Affairs chronic condition spending. Popul Health Manag. 2011;14(6):6.
147. Youssef D, Bailey B, El-Abbassi A, Vannoy M, Manning T, Moorman JP, et al. Healthcare costs of methicillin resistant Staphylococcus aureus and Pseudomonas aeruginosa infections in veterans: role of vitamin D deficiency. Eur J Clin Microbiol Infect Dis. 2012;31(3):6.
148. Youssef D, Bailey B, El Abbassi A, Copeland R, Adebonojo L, Manning T, et al. Healthcare costs of Staphylococcus aureus and Clostridium difficile infections in veterans: role of vitamin D deficiency. Epidemiol Infect 2010;138(9):1322-7.
149. Barnett PG. Research without billing data. Econometric estimation of patient-specific costs. Med Care 1997;35(6):553-63.
150. Barnett PG. Review of methods to determine VA health care costs. Med Care 1999;37(4 Suppl Va):AS9-17.
151. Barnett PG. Determination of VA health care costs. Med Care Res Rev 2003;60(3 Suppl):124S-141S.
152. Barnett PG, Garber AM. The cost of VA-sponsored research. Academic Medicine 1996;71(10):1074-1078.
153. Barnett PG, Swindle RW. Cost-effectiveness of inpatient substance abuse treatment. Health Services Research 1997;32(5):615-629.
154. Bauer MS, Kirk GF, Gavin C, Williford WO. Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study. Journal of Affective Disorders 2001;65(3):231-241.
155. Bauer MS, Shea N, McBride L, Gavin C. Predictors of service utilization in veterans with bipolar disorder: a prospective study. Journal of Affective Disorders 1997;44:159-168.
156. Bennett CL, Curtis JR, Achenbach C, Arno P, Bennett R, Fahs MC, et al. U.S. hospital care for HIV-infected persons and the role of public, private, and Veterans Administration hospitals. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(5):416-421.
157. Bourdette DN, Prochazka AV, Mitchell W, Licari P, Burks J, Group VMSRS. Health care costs of veterans with multiple sclerosis: implications for the rehabilitation of MS. VA Multiple Sclerosis Rehabilitation Study Group. Arch Phys Med Rehabil 1993;74(1):26-31.
158. Brown C. In-house CT program development. Radiol Manage 1991;13(3):36-8.
159. Brown M, Luchi RJ. A Veterans Administration hospital's EKG costs: comparison with those of military and community hospitals. Military Medicine 1980;145(1):26-29.
160. Brown M, Penn RT, Nelson C, Luchi RJ. Cost outcomes and other results from computerizing EKG services. Mil Med 1983;148(5):414-8.
161. Bundt TS. Transcription cost analysis reveals opportunities for savings, efficiencies. J AHIMA 2002;73(8):55-60.
162. Burgess JF, Wilson PW. Technical efficiency in Veterans Administration hospitals. In: Fried HO, Lovell CAK, Schmidt SS, editors. The measurement of productive efficiency: techniques and applications. New York: Oxford University Press; 1993. p. 335-351.
163. Campbell CR, Gillespie KN, Romeis JC. The effects of residency training programs on the financial performance of Veterans Affairs medical centers. Inquiry 1991;28(3):288-299.
164. Cannon JP, Silverman RM. A pharmacist-driven antimicrobial approval program at a Veterans Affairs hospital. Am J Health Syst Pharm 2003;60(13):1358-62.
165. Carey -K, Burgess JF, Jr. On measuring the hospital cost/quality trade-off. Health-Economics 1999;8(6):509-520.
166. Carmichael JM, Alvarez A, Chaput R, DiMaggio J, Magallon H, Mambourg S. Establishment and outcomes of a model primary care pharmacy service system. American Journal of Health-System Pharmacy 2004;61(5):472-82.
167. Chapko MK, Ehreth JL, Hedrick SC. Methods of determining the cost of health care in the Department of Veterans Affairs medical centers and other non-priced settings. Evaluation and the Health Professions 1991;14(3):282-303.
168.Chapko MK, Ehreth JL, Hedrick SC, Rothman ML. Effects of adult day health care on utilization and cost of care for subgroups of patients. Medical Care 1993;31(9 Suppl):SS62-SS74.
169. Chapko MK, Rothman ML, Ehreth JL, Hedrick SC, Sullivan J, Erdly W, et al. Data collection in the Adult Day Health Care Evaluation Study. Medical Care 1993;31(9 Suppl):SS15-SS25.
170. Chapko MK, Weissert WG, Ehreth JL, Hedrick S, Kelly JR. A model for reducing the cost of care in VA medical centers that offer adult day health care. J Aging Health 1990;2(4):501-13.
171. Chou VB, Omer SB, Hussain H, Mugasha C, Musisi M, Mmiro F, et al. The costs associated with adverse event procedures for an international HIV clinical trial determined by activity-based costing. JAIDS 2007;46(4):426-432.
172. Clay P, Vaught E, Glaros A, Mangum S, Hansen D, Lindsey CC. Costs to physician offices of providing medications to medically indigent patients via pharmaceutical manufacturer prescription assistance programs. J Manag Care Pharm 2007;13(6):506-14.
173. Coleman RW, Rodondi LC, Kaubisch S, Granzella NB, O'Hanley PD. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 1991;90(4):439-44.
174. Conney J, Kaston B. Pharmacoeconomic and health outcome comparison of lithium and divalproex in a VA geriatric nursing home population: influence of drug-related morbidity on total cost of treatment. Am J Manag Care 1999;5(2):197-204.
175. Cummings JE, Hughes SL, Weaver FM, Manheim LM, Conrad KJ, Nash K, et al. Cost-effectiveness of Veterans Administration hospital-based home care. A randomized clinical trial. Archives of Internal Medicine 1990;150(6):1274-1280.
176. De Nino LA, Lawrence VA, Averyt EC, Hilsenbeck SG, Dhanda R, Page CP. Preoperative spirometry and laparotomy: blowing away dollars. Chest 1997;111(6):1536-41.
177. Dobscha SK, Anderson TA, Hoffman WF, Winterbottom LM, Turner EH, Snodgrass LS, et al. Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center. Psychiatr Serv 2003;54(2):195-200.
178. Dolder NM, Wilhardt MS, Morreale AP. Justifying a multidisciplinary high-intensity hepatitis C clinic by using decision analysis. American Journal of Health Systems Pharmacy 2002;59(9):867-871.
179. Drexler PG, Lambdin CS. Reducing outpatient costs of nonsteroidal antiinflammatory drugs at a Department of Veterans Affairs teaching hospital. J Pharm Technol 1993;9(1):10-3.
180. Duncan P, Reker D, Kwon S, Lai SM, Studenski S, Perera S, et al. Measuring stroke impact with the stroke impact scale: telephone versus mail administration in veterans with stroke. Med Care 2005;43(5):507-15.
181. Ehreth J, Chapko M, Hedrick SC, Savarino JE. Cost of VA adult day health care programs and their effect on utilization and cost of care. Med Care 1993;31(9 Suppl):SS50-61.
182. Ehreth JL, Chapko MK, Hedrick SC. Financial management of posthospital care programs. Health Care Management Review 1993;18(2):67-76.
183. Elixhauser A, Reker DM, Gillespie KN, Fletcher J, Wolinsky FD. A comparison of in-house and regionalized computerized tomography scanning: clinical impact and cost. Health Services Research 1990;25(1 Pt 2):177-196.
184. Engelhardt JB, Toseland RW, O. Donnell JC, Richie JT, Jue D, Banks S. The effectiveness and efficiency of outpatient geriatric evaluation and management. Journal of the American Geriatrics Society 1996;44(7):847-856.
185. Fries BE, Durance PW, Nerenz DR, Ashcraft ML. A comprehensive payment model for short- and long-stay psychiatric patients. Health Care Financing Review 1993;15(2):31-50.
186. Fries BE, Nerenz DR, Falcon SP, Ashcraft ML, Lee CZ. A classification system for long-staying psychiatric patients. Medical Care 1990;28(4):311-323.
187. Galt KA. Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs Medical Center. Pharmacotherapy 1998;18(5):1103-11.
188. Halpern NA, Bettes L, Greenstein R. Federal and nationwide intensive care units and healthcare costs: 1986-1992. Critical Care Medicine 1994;22(12):2001-2007.
189. Hamilton RA, Gordon T. Incidence and cost of hospital admissions secondary to drug interactions involving theophylline. Annals of Pharmacotherapy 1992;26(12):1507-1511.
190. Hedrick B, Pape TL, Heinemann AW, Ruddell JL, Reis J. Employment issues and assistive technology use for persons with spinal cord injury. J Rehabil Res Dev 2006;43(2):185-98.
191. Hedrick SC, Rothman ML, Chapko M, Ehreth JL, Diehr P, Inui TS, et al. Summary and discussion of methods and results of the Adult Day Health Care Evaluation Study. Medical Care 1993;31(9 Suppl):SS94-SS103.
192. Hedrick SC, Rothman ML, Chapko M, Inui TS, Kelly JR, Ehreth JL. Adult day health care evaluation study: methodology and implementation. Adult Day Health Care Evaluation Development Group. Health Services Research 1991;25(6):935-960.
193. Henry SG, Ness RM, Stiles RA, Shintani AK, Dittus RS. A cost analysis of colonoscopy using microcosting and time-and-motion techniques. J Gen Intern Med 2007;22(10):1415-21.
194. Hosek JR, Palmer AR. Teaching and hospital costs: the case of radiology. J Health Econ 1983;2(1):29-46.
195. Hubbard SL, Fitzgerald SG, Vogel B, Reker DM, Cooper RA, Boninger ML. Distribution and cost of wheelchairs and scooters provided by Veterans Health Administration. J Rehabil Res Dev 2007;44(4):581-92.
196. Hughes SL, Cummings JE, Weaver FM, Manheim LM, Braun B, Conrad KJ. A randomized trial of the cost effectiveness of VA hospital-based home care for the terminally ill. Health Services Research 1992;26(6):801-817.
197. Hughes SL, Cummings JE, Weaver FM, Manheim LM, Conrad KJ, Nash K. A randomized trial of Veterans Administration home care for severely disabled veterans. Medical Care 1990;28(2):135-145.
198. Hughes SL, Weaver FM, Giobbie-Hurder A, Manheim LM, Henderson W, Kubal JD, et al. Effectiveness of team-managed home-based primary care: a randomized multicenter trial. JAMA 2000;284(22):2877-2885.
199. Jubran A, Gross N, Ramsdell J, Simonian R, Schuttenhelm K, Sax M, et al. Comparative cost-effectiveness analysis of theophylline and ipratropium bromide in chronic obstructive pulmonary disease. A three-center study. Chest 1993;103(3):678-684.
200. Kashner TM, Rodell DE, Ogden SR, Guggenheim FG, Karson CN. Outcomes and costs of two VA inpatient treatment programs for older alcoholic patients. Hospital Community Psychiatry 1992;43(10):985-989.
201. Koop G, Carey K. Using seminonparametric methods to model hospital cost functions: The multi-product asymptotically ideal model. Journal of Productivity Analysis 1994;5(2):141-159.
202. Kukull WA, Koepsell TD, Conrad DA, Immanuel V, Prodzinski J, Franz C. Rapid estimation of hospitalization charges from a brief medical record review: evaluation of a multivariate prediction model. Medical Care 1986;24(10):961-966.
203. Lairson DR, Pugh JA, Kapadia AS, Lorimor RJ, Jacobson J, Velez R. Cost-effectiveness of alternative methods for diabetic retinopathy screening. Diabetes Care 1992;15(10):1369-77.
204. Law AV, Pathak DS, Segraves AM, Weinstein CR, Arneson WH. Cost-effectiveness analyses of the conversion of patients with non-insulin-dependent diabetes mellitus from glipizide to glyburide and of the accompanying pharmacy follow-up clinic. Clinical Therapeutics 1995;17(5):977-87.
205. Lindberg KG, Sylvester JC, Boyle PE. The costing out of operational expenses between the Veterans Administration and the Air Force at the New Mexico Regional Federal Medical Center. Military Medicine 1992;157(11):569-573.
206. Murphy CP, Goldspiel BR, Koeller J. Cost of implementing Veterans Administration directives for handling antineoplastic agents. Am J Hosp Pharm 1987;44(4):788-91.
207. Nettleman MD, Fredrickson M, Good NL, Hunter SA. Tuberculosis control strategies: the cost of particulate respirators [see comments]. Annals of Internal Medicine 1994;121(1):37-40.
208. Nugent GN, Hendricks A, Nugent LB, Render ML. Value for taxpayers' dollars: what VA care would cost at medicare prices. Medical Care Research and Review 2004;61(4):495-508.
209. Nyman JA, Martinson MS, Nelson D, Nugent S, Collins D, Wittes J, et al. Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial. Archives of Internal Medicine 2002;162(2):177-182.
210. Oboler SK, Blieden MA, Carter SA, Jahnigen DW, Luck TC, Mathew M, et al. A mobile internal medicine clinic. Archives of Internal Medicine 1983;143(1):97-99.
211. Pappas SH. Describing costs related to nursing. Journal of Nursing Administration 2007;37(1):32-40.
212. Peak T, Toseland RW, Banks SM. The impact of a spouse-caregiver support group on care recipient health care costs. Journal of Aging and Health 1995;7(3):427-449.
213. Puckett SD, Andrews JJ. Sevoflurane use in Veterans Affairs medical centers: utility, safety, and cost-effectiveness. AANA J 1997;65(2):136-42.
214. Raisch DW, Klaurens LM, Hayden C, Malagon I, Pulliam G, Fass R. Impact of a formulary change in proton pump inhibitors on health care costs and patients' symptoms. Digestive Diseases and Sciences 2001;46(7):1533-1539.
215. Reilly PC, Jr., Reilly MC. The cost of outpatient physicians' services at a Veterans Administration hospital. Annals of Internal Medicine 1980;93(1):128-132.
216. Render ML, Nowak J, Hammond EK, Roselle G. Methods for estimating and comparing VA outpatient drug benefits with the private sector. Med Care 2003;41(6 Suppl):II61-9.
217. Render ML, Taylor P, Plunkett J, Nugent GN. Methods to estimate and compare VA expenditures for assistive devices to Medicare payments. Medical Care 2003;41(6 Suppl):II70-9.
218. Roselle G, Render ML, Nugent LB, Nugent GN. Estimating private sector professional fees for VA providers. Medical Care 2003;41(6 Suppl):II23-32.
219. Rosenheck R, Cramer J, Allan E, Erdos J, Frisman LK, Xu W, et al. Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Archives of General Psychiatry 1999;56(6):565-572.
220. Rosenheck R, Cramer J, Xu W, Grabowski J, Douyon R, Thomas J, et al. Multiple outcomes assessment in a study of cost-effectiveness of Clozapine in the treatment of refractory schizophrenia. Health Services Research 1998;33(5):1237-1261.
221. Rosenheck R, Cramer J, Xu W, Thomas J, Henderson W, Frisman L, et al. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. N Engl J Med 1997;337(12):809-815.
222. Rosenheck R, Frisman L, Gallup P. Effectiveness and cost of specific treatment elements in a program for homeless mentally ill veterans. Psychiatric Services 1995;46(11):1131-1139.
223. Rosenheck R, Gallup P, Frisman LK. Health care utilization and costs after entry into an outreach program for homeless mentally ill veterans. Hospital and Community Psychiatry 1993;44(12):1166-1171.
224. Rosenheck R, Neale M, Frisman L. Estimating the capital component of mental health care costs in the public sector. Administration and Policy in Mental Health 1995;21(6):493-509.
225. Rosenheck R, Neale M, Frisman LK. Issues in estimating the cost of innovative mental health programs. Psychiatric Quarterly 1995;66(1):9-31.
226. Rosenheck R, Neale M, Leaf P, Milstein R, Frisman L. Multisite experimental cost study of intensive psychiatric community care. Schizophrenia Bulletin 1995;21(1):129-140.
227. Ryono RA, Jones KS, Coleman RW, Holodniy M. Prescribing practice and cost of antibacterial prophylaxis for surgery at a US Veteran Affairs hospital. Pharmacoeconomics 1996;10(6):630-43.
228. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 2005;352(6):570-85.
229. Scher KS, Bernstein JM, Arenstein GL, Sorensen C. Reducing the cost of surgical prophylaxis. Am Surg 1990;56(1):32-5.
230. Schinka JA, Francis E, Hughes P, LaLone L, Flynn C. Comparative outcomes and costs of inpatient care and supportive housing for substance-dependent veterans. Psychiatr Serv 1998;49(7):946-50.
231. Schneiderman LJ, Kronick R, Kaplan RM, Anderson JP, Langer RD. Effects of offering advance directives on medical treatments and costs. Annals of Internal Medicine 1992;117(7):599-606.
232. Shepard DS, Stason WB, Perry HM, Jr., Carmen BA, Nagurney JT. Multivariate cost-effectiveness analysis: an application to optimizing ambulatory care for hypertension. Inquiry 1995;32(3):320-31.
233. iegel D, Lopez J, Meier J. Pharmacologic treatment of hypertension in the Department of Veterans Affairs during 1995 and 1996. Am J Hypertens 1998;11(11 Pt 1):1271-8.
234. Singletary T, North DS, Weiss M, Marman G. A cost-effective approach to the use of selective serotonin reuptake inhibitors in a Veterans Affairs Medical Center. Am J Manag Care 1997;3(1):125-9.
235. Smith ME, Baker CR, Branch LG, Walls RC, Grimes RM, Karklins JM, et al. Case-mix groups for VA hospital-based home care. Medical Care 1992;30(1):1-16.
236. Stahl CJ, Fox RD. The emergence of a medical school: impact on laboratory utilization and cost containment efforts in an affiliated teaching hospital. Mil Med 1986;151(5):268-74.
237. Stason WB, Shepard DS, Perry HM, Jr., Carmen BM, Nagurney JT, Rosner B, et al. Effectiveness and costs of veterans affairs hypertension clinics. Medical Care 1994;32(12):1197-1215.
238. Stroupe KT, Smith BM, Lee TA, Tarlov E, Durazo-Arvizu R, Huo Z, et al. Effect of increased copayments on pharmacy use in the Department of Veterans Affairs. Med Care 2007;45(11):1090-7.
239. Szentpetery S, Goldman MH, Woody D, Salim J, Mohanakumar T, Lower R. Orthotopic cardiac transplantation in a Veterans Administration hospital. Arch Surg 1984;119(4):390-3.
240. Thomason S, Hawley GG, Wurzel J. Specialty support surfaces: a cost containment perspective. Decubitus 1993;6(6):32-4, 36-8, 40.
241. Volicer L, Collard A, Hurley A, Bishop C, Kern D, Karon S. Impact of special care unit for patients with advanced Alzheimer's disease on patients' discomfort and costs. Journal of the American Geriatric Society 1994;42(6):597-603.
242. Wade TP, Virgo KS, Li MJ, Callander PW, Longo WE, Johnson FE. Outcomes after detection of metastatic carcinoma of the colon and rectum in a national hospital system. Journal of the American College of Surgery 1996;182(4):353-361.
243. Wasson J, Gaudette C, Whaley F, Sauvigne A, Baribeau P, Welch HG. Telephone care as a substitute for routine clinic follow-up. JAMA 1992;267(13):1788-1793.
244. Weaver FM, Conrad KJ, Guihan M, Byck GR, Manheim LM, Hughes SL. Evaluation of a prospective payment system for VA contract nursing homes. Evaluation and the Health Professions 1996;19(4):423-442.
245. Whited JD, Datta SK, Hall RP, Foy ME, Marbrey LE, Grambow SC, et al. An economic analysis of a store and forward teledermatology consult system. Telemedicine Journal and e-Health 2003;9(4):351-60.
246. Wolf MS, Fitzner KA, Powell EF, McCaffrey KR, Pickard AS, McKoy JM, et al. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J Clin Oncol 2005;23(34):8877-83.
247. Wray NP, Weiss TJ, Menke TJ, Gregor PJ, Ashton CM, Christian CE, et al. Evaluation of the VA mobile clinics demonstration project. Journal of Healthcare Management 1999;44(2):133-147.
248. Copeland LA, Berg GD, Johnson DM, Bauer RL. An intervention for VA patients with congestive heart failure. Am J Manag Care 2010;16(3):158-65.
249. Edelman D, Fredrickson SK, Melnyk SD, Coffman CJ, Jeffreys AS, Datta S, et al. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial. Ann Intern Med 2010;152(11):689-96.
250. Frick KD. Microcosting quantity data collection methods. Medical Care 2009;47(7):S76-S81.
251. Hubbard Winkler SL, Vogel B, Hoenig H, Cowper Ripley DC, Wu S, Fitzgerald SG, et al. Cost, utilization, and policy of provision of assistive technology devices to veterans poststroke by Medicare and VA. Med Care 2010;48(6):558-62.
252. Kashner TM, Stensland MD, Lind L, Wicker A, Rush AJ, Golden RM, et al. Measuring use and cost of care for patients with mood disorders: the utilization and cost inventory. Med Care 2009;47(2):184-90.
253. Lairson DR, Chan W, Chang Y-C, del Junco DJ, Vernon SW. Cost-effectiveness of targeted versus tailored interventions to promote mammography screening among women military veterans in the United States. Eval Program Plann 2010.
254. Lipscomb J, Barnett PG, Brown ML, Lawrence W, Yabroff KR. Advancing the science of health care costing. Medical Care 2009;47(7):S120-S126.
255. Liu CF, Rubenstein LV, Kirchner JE, Fortney JC, Perkins MW, Ober SK, et al. Organizational cost of quality improvement for depression care. Health Serv Res 2009;44(1):225-44.
256. Nelson RE, Samore MH, Smith KJ, Harbarth S, Rubin MA. Cost-Effectiveness of Adding Decolonization to a Surveillance Strategy of Screening and Isolation for Methicillin-Resistant Staphylococcus aureus Carriers. Clin Microbiol Infect 2010.
257. Rohrbaugh R, Federman DG, Borysiuk L, Sernyak M. Utilizing VA information technology to develop psychiatric resident prescription profiles. Acad Psychiatry 2009;33(1):27-30.
258. Yoon J, M Yano E, Altman L, Cordasco KM, E Stockdale S, Chow A, et al. Reducing costs of acute care for ambulatory care-sensitive medical conditions: the central roles of comorbid mental illness. Med Care 2012;50(8):705-13.
Last Updated: March 19, 2024
